US Stock MarketDetailed Quotes

Madrigal Pharmaceuticals (MDGL)

Watchlist
  • 510.260
  • +13.230+2.66%
Close May 12 15:59 ET
  • 510.000
  • -0.260-0.05%
Pre 06:26 ET
11.76BMarket Cap-37.83P/E (TTM)

Madrigal Pharmaceuticals (MDGL) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
126.84%311.34M
432.05%958.4M
210.77%321.08M
362.03%287.27M
1,353.76%212.8M
137.25M
180.13M
103.32M
62.18M
14.64M
Operating revenue
126.84%311.34M
432.05%958.4M
210.77%321.08M
362.03%287.27M
1,353.76%212.8M
--137.25M
--180.13M
--103.32M
--62.18M
--14.64M
Cost of revenue
494.88%26.85M
800.82%56.15M
609.67%24.45M
742.10%18.12M
1,325.31%9.07M
4.51M
6.23M
3.45M
2.15M
636K
Gross profit
114.33%284.49M
418.84%902.26M
197.01%296.64M
348.40%269.15M
1,355.06%203.74M
132.74M
173.9M
99.88M
60.02M
14M
Operating expense
77.89%377.21M
78.98%1.2B
113.48%356.24M
117.28%383.12M
42.14%250.94M
39.47%212.05M
76.55%671.78M
42.41%166.87M
78.95%176.33M
104.21%176.54M
Selling and administrative expenses
59.95%268.52M
87.06%813.83M
69.93%239.98M
94.37%209.12M
86.69%196.86M
107.77%167.88M
302.29%435.06M
203.47%141.22M
290.04%107.59M
490.91%105.45M
-General and administrative expense
----
----
----
94.37%209.12M
----
----
----
----
290.04%107.59M
----
Research and development costs
146.07%108.69M
64.13%388.53M
353.32%116.27M
153.13%174M
-23.93%54.08M
-37.99%44.17M
-13.08%236.72M
-63.69%25.65M
-3.11%68.74M
3.62%71.09M
Operating profit
-16.91%-92.72M
39.72%-300.1M
11.03%-59.61M
2.00%-113.98M
70.96%-47.2M
47.83%-79.31M
-30.85%-497.88M
42.82%-67M
-18.03%-116.3M
-88.01%-162.54M
Net non-operating interest income expense
-93.02%424K
-52.93%15.06M
-84.67%1.16M
-69.41%2.86M
-53.03%4.96M
35.08%6.07M
365.82%31.98M
52.15%7.58M
4,633.98%9.34M
1,525.54%10.57M
Non-operating interest income
-12.03%8.24M
-19.91%37.36M
-14.62%9.46M
-20.82%10.31M
-42.15%8.23M
12.43%9.37M
138.30%46.65M
23.75%11.08M
294.75%13.02M
300.51%14.22M
Non-operating interest expense
137.15%7.82M
52.06%22.31M
137.12%8.3M
102.53%7.45M
-10.72%3.26M
-14.10%3.3M
15.41%14.67M
-11.89%3.5M
4.99%3.68M
26.03%3.66M
Other net income (expense)
-2.09M
-3.24M
-128K
-3.07M
-42K
Special income (charges)
----
---2.78M
--0
---2.78M
----
----
--0
--0
--0
----
-Less:Other special charges
----
--2.78M
--0
--2.78M
----
----
----
----
----
----
Other non- operating income (expenses)
---2.09M
---463K
---128K
---293K
---42K
----
----
----
----
----
Income before tax
-28.88%-94.39M
38.12%-288.28M
1.42%-58.58M
-6.76%-114.19M
72.18%-42.28M
50.36%-73.24M
-24.69%-465.89M
47.04%-59.42M
-8.33%-106.96M
-77.12%-151.97M
Income tax
Net income
-28.88%-94.39M
38.12%-288.28M
1.42%-58.58M
-6.76%-114.19M
72.18%-42.28M
50.36%-73.24M
-24.69%-465.89M
47.04%-59.42M
-8.33%-106.96M
-77.12%-151.97M
Net income continuous Operations
-28.88%-94.39M
38.12%-288.28M
1.42%-58.58M
-6.76%-114.19M
72.18%-42.28M
50.36%-73.24M
-24.69%-465.89M
47.04%-59.42M
-8.33%-106.96M
-77.12%-151.97M
Minority interest income
Net income attributable to the parent company
-28.88%-94.39M
38.12%-288.28M
1.42%-58.58M
-6.76%-114.19M
72.18%-42.28M
50.36%-73.24M
-24.69%-465.89M
47.04%-59.42M
-8.33%-106.96M
-77.12%-151.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-28.88%-94.39M
38.12%-288.28M
1.42%-58.58M
-6.76%-114.19M
72.18%-42.28M
50.36%-73.24M
-24.69%-465.89M
47.04%-59.42M
-8.33%-106.96M
-77.12%-151.97M
Basic earnings per share
-24.52%-3.25
41.32%-12.85
5.17%-2.57
-3.25%-5.08
73.24%-1.9
64.63%-2.61
-9.55%-21.9
52.62%-2.71
7.87%-4.92
-51.39%-7.1
Diluted earnings per share
-24.52%-3.25
41.32%-12.85
5.17%-2.57
-3.25%-5.08
73.24%-1.9
64.63%-2.61
-9.55%-21.9
52.62%-2.71
7.87%-4.92
-51.39%-7.1
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 126.84%311.34M432.05%958.4M210.77%321.08M362.03%287.27M1,353.76%212.8M137.25M180.13M103.32M62.18M14.64M
Operating revenue 126.84%311.34M432.05%958.4M210.77%321.08M362.03%287.27M1,353.76%212.8M--137.25M--180.13M--103.32M--62.18M--14.64M
Cost of revenue 494.88%26.85M800.82%56.15M609.67%24.45M742.10%18.12M1,325.31%9.07M4.51M6.23M3.45M2.15M636K
Gross profit 114.33%284.49M418.84%902.26M197.01%296.64M348.40%269.15M1,355.06%203.74M132.74M173.9M99.88M60.02M14M
Operating expense 77.89%377.21M78.98%1.2B113.48%356.24M117.28%383.12M42.14%250.94M39.47%212.05M76.55%671.78M42.41%166.87M78.95%176.33M104.21%176.54M
Selling and administrative expenses 59.95%268.52M87.06%813.83M69.93%239.98M94.37%209.12M86.69%196.86M107.77%167.88M302.29%435.06M203.47%141.22M290.04%107.59M490.91%105.45M
-General and administrative expense ------------94.37%209.12M----------------290.04%107.59M----
Research and development costs 146.07%108.69M64.13%388.53M353.32%116.27M153.13%174M-23.93%54.08M-37.99%44.17M-13.08%236.72M-63.69%25.65M-3.11%68.74M3.62%71.09M
Operating profit -16.91%-92.72M39.72%-300.1M11.03%-59.61M2.00%-113.98M70.96%-47.2M47.83%-79.31M-30.85%-497.88M42.82%-67M-18.03%-116.3M-88.01%-162.54M
Net non-operating interest income expense -93.02%424K-52.93%15.06M-84.67%1.16M-69.41%2.86M-53.03%4.96M35.08%6.07M365.82%31.98M52.15%7.58M4,633.98%9.34M1,525.54%10.57M
Non-operating interest income -12.03%8.24M-19.91%37.36M-14.62%9.46M-20.82%10.31M-42.15%8.23M12.43%9.37M138.30%46.65M23.75%11.08M294.75%13.02M300.51%14.22M
Non-operating interest expense 137.15%7.82M52.06%22.31M137.12%8.3M102.53%7.45M-10.72%3.26M-14.10%3.3M15.41%14.67M-11.89%3.5M4.99%3.68M26.03%3.66M
Other net income (expense) -2.09M-3.24M-128K-3.07M-42K
Special income (charges) -------2.78M--0---2.78M----------0--0--0----
-Less:Other special charges ------2.78M--0--2.78M------------------------
Other non- operating income (expenses) ---2.09M---463K---128K---293K---42K--------------------
Income before tax -28.88%-94.39M38.12%-288.28M1.42%-58.58M-6.76%-114.19M72.18%-42.28M50.36%-73.24M-24.69%-465.89M47.04%-59.42M-8.33%-106.96M-77.12%-151.97M
Income tax
Net income -28.88%-94.39M38.12%-288.28M1.42%-58.58M-6.76%-114.19M72.18%-42.28M50.36%-73.24M-24.69%-465.89M47.04%-59.42M-8.33%-106.96M-77.12%-151.97M
Net income continuous Operations -28.88%-94.39M38.12%-288.28M1.42%-58.58M-6.76%-114.19M72.18%-42.28M50.36%-73.24M-24.69%-465.89M47.04%-59.42M-8.33%-106.96M-77.12%-151.97M
Minority interest income
Net income attributable to the parent company -28.88%-94.39M38.12%-288.28M1.42%-58.58M-6.76%-114.19M72.18%-42.28M50.36%-73.24M-24.69%-465.89M47.04%-59.42M-8.33%-106.96M-77.12%-151.97M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -28.88%-94.39M38.12%-288.28M1.42%-58.58M-6.76%-114.19M72.18%-42.28M50.36%-73.24M-24.69%-465.89M47.04%-59.42M-8.33%-106.96M-77.12%-151.97M
Basic earnings per share -24.52%-3.2541.32%-12.855.17%-2.57-3.25%-5.0873.24%-1.964.63%-2.61-9.55%-21.952.62%-2.717.87%-4.92-51.39%-7.1
Diluted earnings per share -24.52%-3.2541.32%-12.855.17%-2.57-3.25%-5.0873.24%-1.964.63%-2.61-9.55%-21.952.62%-2.717.87%-4.92-51.39%-7.1
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More